v3.26.1
Consolidated Statements of Shareholders' Equity (Unaudited) - USD ($)
$ in Millions
Total
Common Stock
Capital in Excess of Par Value
Retained Earnings
Accumulated Other Comprehensive Loss
Treasury Stock
Non-Controlling Interests
Balance, beginning of period at Dec. 31, 2024 $ 2,126.9 $ 1.2 $ 3,546.1 $ 3,812.3 $ (443.0) $ (4,791.4) $ 1.7
Balance, beginning of period (in shares) at Dec. 31, 2024   118,853,620          
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net earnings 5.6     5.6      
Other comprehensive gain loss (4.1)       (4.1)    
Issuances under equity plans (6.1)   (0.9)     (5.2)  
Issuances under equity plans (in shares)   288,938          
Share-based compensation expense 7.6   7.6        
Repurchases of common stock, including excise tax (25.4)         (25.4)  
Noncontrolling interest transactions             0.4
Balance, end of period at Mar. 31, 2025 2,104.9 $ 1.2 3,552.8 3,817.9 (447.1) (4,822.0) 2.1
Balance, end of period (in shares) at Mar. 31, 2025   119,142,558          
Balance, beginning of period at Dec. 31, 2025 2,060.3 $ 1.2 3,572.5 3,732.3 (412.1) (4,834.3) 0.7
Balance, beginning of period (in shares) at Dec. 31, 2025   119,161,780          
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net earnings 2.5     2.5      
Other comprehensive gain loss 0.0            
Issuances under equity plans (3.1)   (1.1)     (2.0)  
Issuances under equity plans (in shares)   273,799          
Share-based compensation expense 6.0   6.0        
Noncontrolling interest transactions (0.2)           (0.2)
Balance, end of period at Mar. 31, 2026 $ 2,065.5 $ 1.2 $ 3,577.4 $ 3,734.8 $ (412.1) $ (4,836.3) $ 0.5
Balance, end of period (in shares) at Mar. 31, 2026   119,435,579